Powerhouse Ventures
Powerhouse Ventures Limited is a venture capital firm based in Christchurch, New Zealand, with additional offices in Wellington, Dunedin, and Auckland. Established in 2006, the firm specializes in incubation, start-up, early-stage, and growth capital investments, primarily targeting companies within Canterbury. It focuses on sectors such as engineering and clean technology, biotechnology and agri-science, health and medical devices, food, and information technology. Powerhouse Ventures aims to invest in companies that typically do not seek more than NZD 5 million in funding and have total capital and reserves, along with shareholder loans, not exceeding NZD 10 million. The firm is known for its selective approach, rigorously screening opportunities to identify those with strong intellectual property and significant potential in global markets. Additionally, Powerhouse Ventures engages in intellectual property commercialization and operates an innovation education program for students and organizations.
Top Sectors
Top Regions
https://crunchbase.com/organization/***
https://linkedin.com/company/***
Past deals in New Zealand
MARS Bioimaging
Series A in 2014
MARS Bioimaging Ltd. specializes in the design, manufacture, and marketing of advanced imaging systems for medical diagnosis. Established in 2007 and based in Christchurch, New Zealand, the company is recognized for its pioneering MARS imaging system, which utilizes cutting-edge Medipix technology developed in collaboration with the University of Canterbury and licensed from CERN. This system offers high-definition spectral computed tomography, enabling detailed imaging applications, including cancer detection and the development of new contrast agents. MARS Bioimaging also provides a MARS Micro-CT scanner that features an x-ray source and a sophisticated camera system, along with proprietary software that facilitates the visualization of image datasets in both 2D and 3D formats. This innovation positions MARS Bioimaging as a leader in spectral imaging technology, crucial for pre-clinical medical research and other diagnostic applications.
Cirrus Materials Science
Founded in 2013, Cirrus Materials Science specializes in developing nano-technology based coating solutions for metals. Its products include Cirrus Hybrid for protecting light metal substrates and 3D printed components, and Cirrus Dopant, a liquid additive enhancing plating baths. Services comprise electroplating and design services to improve coated material lifespan, reducing maintenance costs.
Objective Acuity
Objective Acuity Limited is a company based in Auckland, New Zealand, specializing in the development of advanced vision testing systems aimed at accurately detecting visual function. The company offers a suite of software-based vision screening tools designed to be accessible and effective for individuals of all ages and literacy levels. Its vision tests utilize an eye-tracking system that captures eye movement data, which is analyzed through proprietary algorithms. This innovative approach allows for the accurate measurement of visual acuity, facilitating early detection of vision problems such as amblyopia and strabismus. Objective Acuity's tests are employed in various applications, including routine screenings for children and adults, follow-up assessments after national screening programs, and objective evaluations of treatment progress by healthcare professionals.
Avalia Immunotherapies
Avalia Immunotherapies develops immunotherapies to support the treatment of cancer, influenza, allergy and other diseases. It designs immune system modulators and therapeutic vaccines that activate immune cells in the body to direct targeted responses against cancer and infectious diseases, with the aim of improving clinical outcomes; the company is based in Lower Hutt, New Zealand.
Upstream Medical Technologies
Upstream Medical Technologies is a medical diagnostics company based in New Zealand, founded in 2015 by Chris Pemberton. The company specializes in testing for cardiovascular diseases, focusing on the development of cardioendocrine biomarkers that facilitate accurate diagnosis of heart disease and its related complications. By utilizing patented technology based on specialized protein peptides, Upstream aims to enable healthcare professionals to detect and treat heart conditions effectively while minimizing harm to patients. The company's innovative pipeline of tests is designed to promote earlier diagnosis, thereby contributing to improved patient recovery outcomes.
Hi-Aspect
Hi-Aspect is a New Zealand-based company specializing in the development of innovative materials derived from protein nanofibril technology. The company focuses on expanding its proprietary technology to introduce novel products aimed at the skincare and wound healing markets. Hi-Aspect's materials, which are sourced from natural ingredients, consist of microscopic nanofibrils that form soft gels in water. These nanofibrils possess unique properties that allow them to bind and stabilize active ingredients, facilitating controlled release applications. By leveraging these advanced materials, Hi-Aspect aims to enhance processes in the cosmetics and healthcare industries, particularly in areas related to blood clotting and wound healing.
Cirrus Materials Science
Founded in 2013, Cirrus Materials Science specializes in developing nano-technology based coating solutions for metals. Its products include Cirrus Hybrid for protecting light metal substrates and 3D printed components, and Cirrus Dopant, a liquid additive enhancing plating baths. Services comprise electroplating and design services to improve coated material lifespan, reducing maintenance costs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.